At 95, Warren Buffett proves he’s still the sharpest dealmaker with $10 billion OxyChem deal ⊕
The transaction reflects Buffett's investment acumen: buying a good business at an attractive price, while skirting the possibility of costly headaches.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
since
auto-detected in 5 stories
62 days ago
63 days ago
found
65 days ago
found
69 days ago
page 1 of 1